Abstract
Preserved human amniotic membrane (AM) is currently being used for a wide spectrum of ocular surface disorders. The AM has a basement membrane, which promotes epithelial cell migration and adhesion. The presence of a unique avascular stromal matrix reduces inflammation, neovascularization and fibrosis. The basic tenets of amniotic membrane transplantation (AMT) are to promote re-epithelialization, to reconstruct the ocular surface and to provide symptomatic relief from surface aberrations. AMT is a useful technique for reconstruction of surface defects resulting from removal of surface tumors and symblephara. AMT has effectively restored a stable corneal epithelium in eyes with, persistent epithelial defects and corneal ulcers. In the setting of acute ocular burns and SJS, AMT has satisfactorily reduced scarring and inflammation. AMT alone may be an effective alternative for partial limbal stem cell deficiency. However remarkable improvements in surface stability have resulted from concurrent AMT and limbal stem cell transplantation, wherein the limbal grafts are obtained from the normal fellow eye, living relative or cadaveric eye. In severe or bilateral cases, well being of the donor eye is a major concern. Currently, the most unique application of preserved human AM in ophthalmology is its use as a substrate for ex-vivo expansion of corneal and conjunctival epithelium. In this novel technique of tissue engineering, epithelial stem cells can be safely harvested and expanded on denuded AM. The resultant composite cultured tissue has been successfully transplanted to restore vision, as well as the structure and function of damaged ocular surfaces.
Similar content being viewed by others
References
Anderson D., Ellies P., Pires R.T.F. and Tseng S.C.G. 2001. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br. J. Ophthalmol. 85: 567–575.
Araki-Sasaki K., Ohashi Y., Sasabe T. and Hayashi K., et al. 1995. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci. 36: 614–621.
Azuara-Blanco A., Pillai C.T. and Dua H.S. 1999. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol. 83: 300–402.
Barabino S., Rolando M. and Bentivoglio G. et al. 2003. Role of conjunctival reconstruction in ocular cicatricial pemphigoid. Ophthalmology 110: 474–480.
Choi Y.S., Kim J.Y., Wee W.R. and Lee J.H. 1998. Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratect-omy. Cornea 17(4): 389–395.
Cohen E.J. 2001. Use of autologous limbal epithelial cells cul-tured on amniotic membrane for unilateral stem cell deficiency. Arch. Ophthalmol. 119: 123.
Davenger M. and Evensen A. 1971. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 229: 560–561.
De Roth 1940. Plastic repair of conjunctival defects with fetal membrane. Arch. Ophthalmol. 23: 522–525.
Dua H.S. and Azuara-Blanco A. 2000a. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br. J. Ophthalmol. 84: 273–278.
Dua H.S. and Azuara-Blanco A. 2000b. Limbal stem cells in corneal Epithelium. Surv. Ophthalmol. 44: 415–425.
Espana E.M., Prabhasawat P., Grueterich M., Solomon A., Tseng S.C. 2002. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br. J. Ophthalmol. 86(6): 640–645.
Espana E.M., Grueterich M., Sandoval H. et al. 2003. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J. Cataract. Refract. Surg. 29: 279–284.
Fukuda K., Chikama T., Nakamura M. and Nishida T. 1999. Differential distribution of sub-chains of the basement mem-brane components type IV collagen and laminin among the amniotic membrane, cornea and conunctiva. Cornea 18: 73–79.
Gomes J.A.P., Santos M.S. and Cunha M.C. et al. 2003. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 110: 466–473.
Grueterich M. and Tseng S.C.G. 2002. Human limbal progeni-tor cells expanded on intact amniotic membrane ex-vivo. Arch. Ophthalmol. 120: 783–790.
Grueterich M., Espana E.M. and Touhami A. et al. 2002. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology 109: 1547–1552.
Hanada K., Shimazaki J. and Shimmura S. et al. 2001. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am. J. Ophthalmol. 131: 324–331.
He Y.G., Alizadeh H., Kinoshita K. and McCulley J.P. 1999. Experimental transplantation of cultured human limbal and amniotic epithelial cells onto the corneal surface. Cornea 18: 570–579.
Honavar S.G., Bansal A.K., Sangwan V.S. and Rao G.N. 2000. Amniotic membrane transplantation for ocular surface reconstruction in Stevens Johnson syndrome. Ophthalmology 107: 975–979.
Kenyon K.R. and Tseng S.C.G. 1989. Limbal autograft trans-plantation for ocular surface disorders. Ophthalmology 96: 709–723.
Kenyon K.R., Wagoner M.D. and Hettinger M.E. 1995. Conjunctival autograft transplantation of advanced and recurrent pterygium. Ophthalmology 92: 1461–1470.
Khoudadoust A.A., Silverstein A.M. and Kenyon D.R. et al. 1968. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am. J. Ophthalmol. 65: 339–348.
Kim J.C. and Tseng S.C. 1995. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14: 473–484.
Koizumi N., Inatomi T. and Quantock A.J. et al. 2001. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108: 1569–1574.
Kouzumi N., Fullwood N.J. and Bairaktaris G. et al. 2000. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 41: 2506–2513.
Koizumi N., Inatomi T. and Quantock A.J. et al. 2000. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologus transplantation in rabbits. Cornea 19: 65–71.
Kruse F.E., Rohrschneider K. and Volcker H.E. 1999. Multilayer layer amniotic membrane transplantation for reconstruction deep corneal ulcers. Ophthalmology 106: 1504–1511.
Lee S.B., Li D.Q., Tan D.T.H., Meller D.C. and Tseng S.C. 2000. Suppression of TGF β signaling in both normal conjunctival fibroblasts and pteryigial body fibroblasts by amniotic membrane. Curr. Eye Res. 20(4): 325–334.
Lee S.-H. and Tseng C.G. 1997. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am. J. Ophthalmol. 123: 303–312.
Letko E., Stechschulte S.U. and Kenyon K.R. et al. 2001. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch. Ophthalmol. 119: 659–663.
Ma D.H., See L.C., Liau S.B. and Tsai R.J. 2000. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br. J. Ophthalmol. 84(9): 973–978.
Meller D. and Tseng S.C.G. 1999. Conjunctival epithelial cell differentiation on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 40: 878–886.
Meller D., Pires R.T.F. and Mack R.J.S. et al. 2000. Amniotic membrane transplantation of acute chemical or thermal burns. Ophthalmology 107: 980–990.
Paridaens D., Beekhuois H. and Bosch W. et al. 2001. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br. J. Ophtahlmol. 85: 658–661.
Pellegrini G., Traverso C.E. and Franzi A.T. et al. 1997. Long term restoration of damaged corneal surface with autologus cultivated corneal epithelium. Lancet 349: 990–993.
Pires R.T.F., Tseng S.C.G. and Prabhasawat P. et al. 1999. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch. Ophthalmol. 117: 1291–1297.
Puangsricharern V. and Tseng S.C.G. 1995. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102: 1476–1485.
Sangwan V.S. and Tseng S.C.G. 2001. New Perspectives in ocular surface disorders. An integrated approach for diagno-sis and management. Indian J. Ophthalmol. 49: 153–168.
Sangwan V.S., Murthy S.I., Bansal A.K. and Rao G.N. 2003. Surgical treatment of chronically recurring pterygium. Cornea 22(1): 63–65.
Sato H., Shimazaki J. and Shinozaki N. 1998. Role of growth factors for ocular surface reconstruction after amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 39: S428.
Schwab I.R., Reyes M. and Isserhoff R.R. 2000. Successful transplantation of bioengineered tissue in patients with ocular surface disease. Cornea 19: 421–426.
Shields C.L., Shields J.A., Armstrong T. 2001. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am. J. Ophthalmol. 132(4): 576–578.
Shimazaki J., Kosaka K., Shimmura S. and Tsubota K. 2003. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 110: 119–124.
Shimazaki J., Yang H. and Tsubota K. 1997. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104: 2068–2076.
Shimmura S., Shamazaki J., Ohashi Y. and Tsubota K. 2001. Anti-inflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20: 408–413.
Sippel K.C., Ma J.J.K. and Foster C.S. 2001. Amniotic membrane surgery. Curr. Opin. Ophthalmol. 12: 269–281.
Sorsby A. and Symons H.M. 1946. Amniotic membrane grafts in caustic burns of the eye. Br. J. Ophthalmol. 30: 337–345.
Solomon A., Rosenblatt M. and Monroy D. et al. 2001. Suppression of Interleukin 1 alpha and Interleukin 1 beta in the human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br. J. Ophthalmol. 85: 444–449.
Sridhar M.S., Bansal A.K., Sangwan V.S. and Rao G.N. 2000. Amniotic membrane transplantation in acute chemical and thermal injury. Am. J. Ophthalmol. 130: 134–137.
Sridhar M.S., Sangwan V.S., Bansal A.K. and Rao G.N. 2001. Amniotic membrane transplantation in the management of shield ulcers of vernal keratoconjunctivitis. Ophthalmology 108: 1218–1222.
Ti S.E. and Tseng S.C. 2002. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr. Opin. Ophthalmol. 13(4): 204–212.
Ti S., Anderson D., Touhami A. et al. 2002. Factors affecting outcome following transplantation of ex vivo expanded limbal epithelium on amniotic membrane for total limbal deficiency in rabbits. Invest. Ophthalmol. Vis. Sci. 43: 2584–2592.
Tsai R.J.F. 1998. Corneal surface reconstruction by amniotic membrane with cultivated autologus limbo-corneal epithelium. Invest. Ophthalmol. Vis. Sci. 39: S429.
Tsai R.J., Li L. and Chen J. 2000. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. New Eng. J. Med. 343: 86–93.
Tseng S.C.G., Prabhasawat P. and Lee S.H. et al. 1997. Amniotic membrane transplantation for conjunctival surface reconstruction. Am. J. Ophthalmol. 1234: 765–774.
Tseng S.C.G., Prabhaswat P., Barton K. 1998. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. 116: 431–441.
Tseng S.C.G. 1989. Concept and application of limbal stem cells. Eye 3: 141–157.
Tsubota K., Satake Y. and Ohyama M. et al. 1996. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens Johnson syndrome. Am. J. Ophthalmol. 122: 38–52.
Wagoner M.D. 1997. Chemical injures of the eye: Current concepts in pathophysiology and therapy. Surv. Ophthalmol. 41: 275–313.
Woo H.M., Kim M.S. and Kweon O.K. et al. 2001. Effects of amniotic membrane on epithelial wound healing and stromal remodeling after excimer laser keratectomy in rabbit corneas. Br. J. Ophthalmol. 85: 345–349S.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burman, S., Tejwani, S., Vemuganti, G.K. et al. Ophthalmic Applications of Preserved Human Amniotic Membrane: A Review of Current Indications. Cell Tissue Banking 5, 161–175 (2004). https://doi.org/10.1023/B:CATB.0000046067.25057.0a
Issue Date:
DOI: https://doi.org/10.1023/B:CATB.0000046067.25057.0a